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INTRODUCTION
Body weight is finely regulated through energy expenditure, nutritional, neuronal and hormonal signals. Organs such as brain, pancreas, liver, skeletal muscle and adipose tissue can integrate these endogenous or environmental factors to ensure metabolic homeostasis.
Prolactin (PRL), initially identified for its ability to stimulate mammary gland development and lactation was thereafter suspected to exert pleiotropic functions, including effects on growth, development, immunoregulation, brain and behavior, electrolyte and energy homeostasis (1) (2) (3) . However, the physiological relevance of most of these functions in humans remains an open issue.
The biological actions of PRL are mediated by its interaction with PRL receptor (PRLR), a member of the cytokine receptor superfamily (4, 5) . Compared to growth hormone and its cognate receptor, the actions of PRL and PRLR on metabolic homeostasis under non-lactating conditions have received less attention. However, within the last decade, a wealth of experimental data has documented the potential role of PRLR signaling in body weight regulation, pancreas development and insulin secretion, and adipose tissue physiology (3).
Regarding body weight regulation, some conflicting results have emerged from PRLR -/-mice while decreased weight gain was observed in 8-9 mo-old PRLR -/-females (6). This was not confirmed by subsequent studies in younger animals (7, 8) .
Interestingly, several reports described higher body weight in humans with prolactinoma, but the mechanisms underlying this association are poorly understood and likely pleiotropic (9) . Some authors suggest that weight loss in humans occurs after complete or near normalization of serum PRL with dopamine agonists (10) . Several lines of evidence support a direct role for PRL in adipogenesis. PRL enhances the expression of C/EBP and PPAR in NIH-3T3, two master genes of adipogenesis (11) . Lack of PRLR in mice results in an impaired development of both parametrial and subcutaneous adipose tissues associated with a lower number of adipocytes without change in their volume (8) . PRL signaling also alters lipid metabolism through inhibition of lipoprotein lipase activity in human white adipose tissue and inhibits adipokine release including leptin, adiponectin and IL-6 (12). In addition, PRL potentiates the insulin effect on leptin release in cultured brown adipocytes (13) . Most important, PRL signaling is essential for normal perinatal brown adipocyte thermogenesis.
Newborn mice lacking PRLR have hypotrophic BAT depots that express low levels of adipogenic markers reducing mouse viability during cold challenge (14) . Moreover, immortalized PRLR -/-preadipocytes fail to undergo differentiation into mature brown adipocytes, and could be rescued by reintroduction of PRLR (14) . Interestingly, PRL is also released both by primary preadipocytes and adipose explants and its expression changes according to white adipose tissue localization, suggesting a potential autocrine-paracrine loop in a depot specific manner (15) .
Although all these experimental data converge to support a physiological role of PRLR in the control of energy homeostasis, the pathophysiological involvement of this receptor on adipocyte plasticity remains unclear. The aim of the present study was to clarify the potential adaptive function of PRL signaling under obesogenic conditions. For this purpose, we subjected PRLR -/-mice to a high fat diet (HFD) for 16 weeks and analyzed their metabolic phenotypes. Remarkably, PRLR -/-mice were highly resistant to HFD-induced obesity, a phenomenon that involves a brown conversion of white fat depots defined as beigeing (16, 17) . Thus, manipulations of the PRL signaling pathway could hopefully be translated into adjunct therapy to raise energy expenditure and promote weight loss.
MATERIALS AND METHODS

Mice
Eight-wk-old PRLR -/-and wild type male mice, on a pure 129/SvJ background, were kept on a 12:12 h light-dark cycle in a temperature-controlled colony room and had ad libitum access to tap water and were challenged for 16 weeks with standard chow (SC) (17% fat, 23%
protein, 60% carbohydrates, Harlan, Gannat, France) or high fat diet (HFD) (60% fat, 20%
protein, 20% carbohydrates, Research Diets, Denmark) (18) . Body weight was measured weekly. Mice were sacrificed and tissues were removed, weighed and used for subsequent gene expression and histological analyses. All procedures were approved by the Ministère de l'Agriculture, France.
Body fat determination
Body weight composition was evaluated by Dual-Energy X Ray Absorptiometry (DEXA) using a PIXIMUS apparatus (LUNAR Corporation; Madison, WS, USA). Mice were anesthetized by ip injection (100 µl/10 g BW) of a saline mixture containing 0.1 % Xylazin (Rompun, Bayer Pharma; Puteaux, France) and 10 mg/ml of Ketamin (Imalgène 1000, Merial, Lyon, France). Fat mass and lean masses were calculated according to computerized measurements of Piximus apparatus.
Metabolic parameters exploration
Mice were analyzed for whole body energy expenditure, and oxygen consumption (VO 2 ), food intake (g) and spontaneous activities using calorimetric cages with bedding, and had ad libitum access to food and water (Labmaster, TSE Systems GmbH, Bad Homburg, Germany). Mice were monitored for body weight and composition at entry and exit of the experiment.
Body mass composition (lean tissue mass, fat mass, free water and total water content) was analyzed using an EchoMRI (Whole Body Composition Analyzers, Echo Medical Systems, Houston, USA). Data analysis was performed using extracted value of VO 2 consumed, (expressed in ml/kg/h), and energy expenditure (kcal/kg/h).
Plasma measurements
Blood was collected at sacrifice and plasma insulin from 16 h-fasting mice was measured using the Ultra Sensitive Insulin ELISA kit (Crystal Chem Inc, Downer Grove, USA).
Glycemia was determined with Accu-Chek Performa Glucometer (Roche, Bâle, Swisserland).
Plasma leptin and resistin were measured using the MADPK-71K kit (Millipore, Molsheim, France). Total cholesterol levels were determined by enzymatic colorimetric assays (Sobodia, Montbonnot-Saint-Martin, France).
Homeostasic model assessment (HOMA) determination
HOMA-IR and HOMA-index were used to quantify insulin resistance and beta cell function, respectively. These indexes were determined as follows: HOMA-IR = (glucose x insulin)/405 and HOMA-= (γ60 x insulin)/(glucose -63) %. Fasting glucose and insulin are expressed as mg/dL and mU/L, respectively.
Immunocytochemical and histomorphological procedures
Tissues were fixed overnight in 4% paraformaldehyde, dehydrated, embedded in paraffin, and Percentage of brown adipose tissue (BAT) was determined by calculating BAT area on total area of perirenal adipose tissue.
Western blot analyses
Total protein extracts were prepared from perirenal WAT isolated from mice. Briefly, WAT was lysed as described previously (13) with an Odyssey Fc apparatus (LI-COR). GAPDH protein was used as an internal control:
blots were incubated for 1 h at room temperature with rabbit anti-GAPDH (1:5,000) (Sigma, Saint-Quentin Fallavier, France) followed by 1 h incubation at RT with an IRDye 800-conjugated affinity purified anti-rabbit secondary antibody (1:10,000, Thermo Scientific, Illkirch, France). UCP1 infrared fluorescence was normalized to GAPDH as determined by densitometry using the Image Studio software (LI-COR).
Positron emission tomography
Positron emission tomography (PET) recording was carried out on 6-mo-old male mice with 2-[ 18 F]fluoro-2-deoxyglucose (18F-FDG), a 18 F-labeled glucose analogue which is known to be actively trapped by activated BAT in mice (19, 20 image-reconstruction, the volume of the foci with high FDG activity were determined using a threshold value of 2 standardized uptake value (SUV): 1) within the interscapular area, which is known to be a depot of BAT in normal mice (19, 20) , and 2) along the remaining part of the dorsal walls from the thorax and abdomen and thus, in sites known to normally involve WAT in normal conditions.
Gene expression analyses
Quantitative real-time PCR was performed as described previously (14) . After DNAse I treatment, RNA was reverse-transcribed and used for quantitative RT-PCR (qRT-PCR) using the Power SYBR ® Green PCR Master Mix (Applied Biosystems). Final primer concentrations were 300 nM (see Table 1 for primer sequences). Reaction parameters were carried out on a
StepOne™ Real-Time PCR System (Applied Biosystems). Relative expression within a given sample was calculated as a ratio (amol of specific gene/fmol of 18S). Results are means ± SEM.
Data analysis
Data are expressed as means ± SEM. Data were analyzed using a non parametric Mann 
RESULTS
PRLR -/-mice are resistant to high fat diet-induced obesity despite high food intake
Previous studies on PRLR -/-mice showed a mild body weight difference compared to wild type mice (6) . We examined whether this receptor inactivation affects body weight regulation.
We found that PRLR knock-out resulted in a small decrease in the body weight gain over the 24 weeks when male mice were maintained on standard chow (SC) (Fig. 1A) . To further investigate the metabolic impact of PRL signaling, we subjected the PRLR -/-and control mice to a high fat diet (HFD). As expected, 16 weeks of ad libitum HFD feeding caused a sharp increase in body weight in both groups; however, PRLR -/-mice gained 16% less weight than controls during the same period (Fig. 1A , p< 0.001). This difference of body weight was associated with a profound reduction of adipose mass with no difference in the lean mass as revealed by DEXA method (Fig. 1B, 1C p< 0.01). Indeed, examination of body fat mass revealed a marked 40% reduction of the perirenal adipose pad normalized to body weight in PRLR -/-mice (Fig. 1D, p<0 .01) while gonadal and subcutaneous WAT depots, kidney and spleen weights (Figs. 1 E-H) were similar, pointing to a genotypic and diet-related difference in site-specific adipose depots.
To investigate the mechanisms underlying the resistance to HFD-induced obesity of PRLR -/-mice, we measured behavioral and metabolic adjustments to the diet, given that energy intake should equal energy expenditure to maintain energy homeostasis. As depicted in Fig. 2A , over 4 consecutive days in metabolism cages, cumulative food intake on SC was significantly increased in PRLR -/-mice compared to controls, the same trend was observed when animals were HFD fed. No change in locomotor activity was detected between the groups ( Supplementary Fig. 1 ). Oxygen consumption and energy expenditure were significantly increased in PRLR -/-mice as compared to WT mice both under SC and after 16
weeks of HFD feeding regimen (Figs. 2B and 2C ). Under HFD, diet-induced enhancement of metabolic rate and energy expenditure, normalized to lean mass, were calculated at 9.5% and 9.8% in control mice, but increased up to 12.8% and 11.9% in PRLR -/-mice, respectively.
Taken together, our data demonstrate that PRL signaling is involved in normal energy expenditure and body weight regulation.
PRLR -/-mice are protected against HFD-induced insulin resistance
To further assess the impact of PRLR deletion on glucose metabolism, we showed that under Leptin levels were elevated after HFD feeding in both groups, but they were significantly lower in the PRLR -/-mice than in control mice as expected from lesser weight gain (Fig. 3E) .
Finally, in contrast to WT mice, resistin levels were unchanged in PRLR -/-mice, whatever the diet, excluding a major contribution of this insulin action inhibitor in the prevention of HFDinduced glucose intolerance (Fig. 3F) .
BAT-like remodeling of perirenal wat in PRLR -/-mice
We next explored whether the resistance to HFD-induced body weight gain in PRLR -/-mice was associated with histomorphological modifications of fat depots. Both subcutaneous and gonadal WAT disclosed a marked reduction of adipocyte size in PRLR -/-mice under HFD, consistent with the global decrease in fat mass (Supplementary Fig. 2 ). This suggests a major impact of PRL signaling on the adipocyte metabolic activity. Several multilocular brown-like adipocytes were detected in perirenal WAT of PRLR -/-HFD-fed males (Fig. 4A) . In contrast, significantly fewer brown-like adipocytes were found embedded in the perirenal fat depot of PRLR +/+ HFD-fed mice (Fig. 4A) . Quantification of brown-like adipose area in the perirenal tissues showed a dramatic increase of the emergence of browning (Fig. 4B ), suggesting that in the absence of PRL signaling, HFD induces BAT-like remodeling of perirenal WAT as revealed by BAT-specific uncoupling protein 1 (UCP1) immunostaining (Fig. 4C ). These observations were confirmed by western blot analysis ( Interestingly, this adaptive brown like-cell programming is highly dependent on the location of adipose depots, in subcutaneous but not gonadal fat ( Supplementary Fig. 3 ) in accordance with the well-known plasticity of specific fat depot (22, 23) . Altogether, these data indicate that the lack of PRL signaling selectively facilitates BAT-like remodeling under specific metabolic conditions.
Altered pRb/Foxc2 pathway is a key molecular switch for beige cell emergence
We next investigated the molecular mechanisms by which the absence of PRL signaling is associated with the emergence of UCP1-expressing beige fat cells and resistance to HFDinduced obesity. We focused our attention on the retinoblastoma protein (pRb), a transcription factor involved in cell cycle, previously reported as a downstream effector of PRL signaling (24) . In addition, given that pRb plays a key role in fate choice of differentiating common mesenchymal precursors toward adipocytes (25), we hypothesized that pRb could regulate adipocyte differentiation and beige conversion. pRb expression was drastically increased upon HFD whatever the genotype (Fig.. 5C upper panel) ; however, PRLR-/-mice displayed a marked reduction of pRb expression in perirenal depots as compared to PRLR+/+ mice.
We also investigated Foxc2 expression, another important transcriptional factor regulating adipocyte metabolism and mitochondrial function (26) . Foxc2 expression was significantly reduced in PRLR -/-mice under SC as compared to PRLR +/+ mice, concomitant with the reduction of adipogenic markers (see Fig. 5C lower panel) . In contrast, Foxc2 mRNA levels were greatly enhanced under HFD, consistent with the prominent role of this forkhead transcription factor as a key metabolic regulator of brown adipocytes.
Hence, our experiments demonstrate that in mice lacking PRLR, both perirenal and subcutaneous WAT have acquired a brown fat-like phenotype under HFD referred to as "beigeing". In addition, the coordinated changes in pRb and Foxc2 pathways may constitute a molecular switch for preferential metabolic transdifferentiation in this model.
DISCUSSION
While PRL is known as the pituitary hormone of lactation, accumulating evidence shows that it exerts pleiotropic effects including growth and metabolic actions (2, 3) . Here, we demonstrate that PRLR is an important effector modulating adipocyte fate and differentiation with impact on energy homeostasis and adaptive thermogenesis.
Despite increased food intake in both SC and HFD, PRLR -/-mice remained leaner than controls and were protected against HFD-induced obesity with a marked reduction in adiposity, notably in perirenal fat mass. Thus, we hypothesized that change in overall energy expenditure may be at least in part responsible for this phenotype. This was supported by increased O 2 consumption and enhanced heat dissipation that were significantly higher in PRLR -/-mice as compared to PRLR +/+ mice. The relative resistance to HFD-induced obesity was accompanied by a more favorable carbohydrate homeostatic profile in PRLR -/-mice, consistent with the major implication of PRL signaling in energy balance. However, these changes in whole body homeostasis were likely not sufficient to account for the robust protection against HFD-induced weight gain. Increased energy expenditure through BAT activation constitutes a powerful mechanism by which high calorie intake could be dissipated, thereby defending against obesity (27) . Indeed, enhanced conversion of white to thermogenically active adipocytes observed in PRLR -/-mice seems to be the key regulatory event involved in protection against HFD-induced obesity, consistent with a role of PRL signaling in adipocyte fate determination and/or reprogramming.
In accordance with PRL-mediated transcriptional control of proadipogenic factors (11) Gonadal and subcutaneous white fat pads of Fsp27 -/-mice are reduced in size compared to wild type mice, together with the acquisition of BAT-like phenotype (35) . Collectively, these findings underscore the implication of pRb pathway in adipocyte fate, in accordance with the pRb defect observed in PRLR -/-fat depots. It was shown that pRb-deficient mouse embryonic fibroblasts exhibited an increased expression of the Forkhead transcription factor Foxc2 that accompanied a white to brown adipocyte transdifferentiation (36) . Similarly, overexpression of Foxc2 in adipose tissue leads to a lean and insulin-sensitive phenotype accompanied by an increased BAT-like function due to an enhanced mitochondrial biogenesis through activation of mitochondrial transcription factors (26, 37) . PRLR -/-mice under HFD displayed a sharp increase in Foxc2 expression, in agreement with the involvement of pRb/Foxc2 pathway in the "beigeing" conversion. The functional role of PRL signaling seems to be highly dependent upon the developmental stage. Indeed, we have demonstrated that PRLR is pivotal for early development of BAT to support neonatal thermogenesis (14) . In contrast, during adulthood, the absence of PRL signaling is associated with beige conversion, most notably as an adaptive mechanism to facilitate high fat-induced thermogenesis. Thus, PRL signaling plays important but changing roles in energy homeostasis during the lifespan. This is reminiscent of the metabolic action of PRL reported in amphibians (38) , fish and birds (1) property of PRL (39, 40) , the genetic association between PRL and obesity (41, 42) and the relationship between hyperprolactinemia and obesity (43, 44) . Several recent reports confirmed the major role of BAT in the control of energy balance. Thermogenic UCP1-expressing cells are found interspersed in adult human subcutaneous fat yet their presence negatively correlates with weight gain and insulin resistance (45) (46) (47) (48) (49) . It would be relevant to examine whether patients with hyperprolactinemia are less prone to develop a functional BAT in response to cold exposure or overfeeding using PET. In sum, our work demonstrates that mice lacking PRLR are highly resistant to HFD-induced obesity, owing to the emergence of a brown adipose-like phenotype in peculiar white fat depots. This is associated with a concomitant increase of PRDM16, PGC1, AdR3 and Foxc2 that constitutes a molecular switching mechanism. This in turn converges towards an activation of thermogenic brown capacity with the final increase of UCP1 responsible for heat dissipation and resistance to high calorie weight gain. We thus propose that PRL signaling represents an additional determinant of energy homeostasis during physiological and pathophysiological conditions.
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